Calretinin interneurons are early targets of extracellular amyloid-beta pathology in PS1/AbetaPP Alzheimer mice hippocampus.
Specific neuronal networks are preferentially affected in the early stages of Alzheimer's disease (AD). The distinct subpopulations of hippocampal inhibitory GABAergic system have been shown to display differential vulnerability to neurodegeneration in AD. We have previously reported a substantial loss of SOM/NPY interneurons, whereas those expressing parvalbumin were unaltered, in the hippocampus of 6 month-old PS1/AbetaPP transgenic mice. In the present study, we now investigated the pathological changes of hippocampal calretinin (CR) interneurons in this PS1/AbetaPP model from 2 to 12 months of age. The total number of CR-immunoreactive inhibitory cells was determined by stereology in CA1 and CA2/3 subfields. Our findings show a substantial decrease (35%-45%) of CR-positive interneurons in both hippocampal subfields of PS1/AbetaPP mice at very early age (4 months) compared to age-matched control mice. This decrease was accompanied by a reduced CR mRNA content as determined by quantitative RT-PCR. However, the number of another hippocampal CR-positive population (belonging to Cajal-Retzius cells) was not affected. The selective early loss of CR-interneurons was parallel to the appearance of extracellular Abeta deposits, preferentially in CR-axonal fields, and the formation of dystrophic neurites. This specific GABAergic subpopulation plays a crucial role in the generation of synchronous rhythmic activity in hippocampus by controlling other interneurons. Therefore, early alterations of hippocampal inhibitory functionality in AD, caused by select CR-cells neurodegeneration, could result in cognitive impairments seen in initial stages of the disease.
Baglietto-Vargas
David
D
Dpto Biología Celular, Facultad de Ciencias, Universidad de Málaga, Málaga, Spain.
Moreno-Gonzalez
Ines
I
Sanchez-Varo
Raquel
R
Jimenez
Sebastian
S
Trujillo-Estrada
Laura
L
Sanchez-Mejias
Elisabeth
E
Torres
Manuel
M
Romero-Acebal
Manuel
M
Ruano
Diego
D
Vizuete
Marisa
M
Vitorica
Javier
J
Gutierrez
Antonia
A
D000367:Age Factors; D000544:Alzheimer Disease / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D016229:Amyloid beta-Peptides / Q000378:metabolism*; D016564:Amyloid beta-Protein Precursor / Q000235:genetics*; D000704:Analysis of Variance; D000818:Animals; D064032:Calbindin 2; D004195:Disease Models, Animal; D005786:Gene Expression Regulation / Q000235:genetics; D006624:Hippocampus / Q000473:pathology*; D006801:Humans; D007395:Interneurons / Q000378:metabolism*; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D010751:Phosphopyruvate Hydratase / Q000378:metabolism; D053764:Presenilin-1 / Q000235:genetics*; D064030:S100 Calcium Binding Protein G / Q000378:metabolism*
D016229:Amyloid beta-Peptides; D016564:Amyloid beta-Protein Precursor; C576764:CALB2 protein, human; C576511:Calb2 protein, mouse; D064032:Calbindin 2; D053764:Presenilin-1; D064030:S100 Calcium Binding Protein G; D010751:Phosphopyruvate Hydratase